Doval

Brief Profile

With an experience of more than 37 years in Medical Oncology, Dr. Doval is the epitome of dedication. He specializes in the treatment of solid tumors, with a particular focus on patients with breast and lung cancers. An academically oriented researcher and physician, Dr. Doval has been involved in more than 60 clinical studies. A pioneer in his field, Dr. Doval is guiding Mestastop by providing the valuable clinician perspective.

Dr. Dinesh C Doval

MBBS, MD (MEDICAL ONCOLOGY)

Designation:Chair Medical Oncology & Chief of Breast & Thoracic Services, RGCI
Location:Delhi

Awards & Certifications

 RGCI : Outstanding Contribution Award, 2014.
 Chairman’s Award RGCIRC Excellence in Clinical Research 2011

Nexus Venture Partners

Pudnaa

Developer

“Arnab’s passion to solve this problem is admirable”

Dr. D.C Doval

Krishnan D

Developer

“If Mestastop can predict metastasis probability of primary cancer patients, that will be a game changer for doctors”

Dr. A. K Vaid

Doctor

Developer

“Mestastop provides a great opportunity at finding solutions to the unmet medical needs in cancer care”